Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

MORE ABOUT IDU

MORE ABOUT IDU This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract To the Editor: —After reading Dr. Kaufman's solicited comments on my letter to you, I feel, in the interest of clarity, that some additional statements should be made.I certainly have no quarrel with Dr. Kaufman's position that IDU represents a significant advance in the therapy of herpetic keratitis. Indeed, studies with our own preparation of IDU certainly tend to support the therapeutic findings presented in his article with Drs. Nesburn and Maloney in the May issue of the Archives.In defense of my comment that IDU inhibits both viral and cellular DNA, I should like to call attention to Dr. Kaufman's statement in his article (p. 590) where he points out that after all, "this drug was developed because of possible cytotoxic properties"; therefore, the logical assumption is that it does affect cellular DNA. In order to inhibit effectively the abnormally large amount of DNA being synthesized within a http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Ophthalmology American Medical Association

MORE ABOUT IDU

Abstract

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract To the Editor: —After reading Dr. Kaufman's solicited comments on my letter to you, I feel, in the interest of clarity, that some additional statements should be made.I certainly have no quarrel with Dr. Kaufman's position that IDU represents a significant advance in the therapy of herpetic keratitis. Indeed, studies with our own...
Loading next page...
 
/lp/american-medical-association/more-about-idu-g9KmV2ef0B
Publisher
American Medical Association
Copyright
Copyright © 1962 American Medical Association. All Rights Reserved.
ISSN
0003-9950
eISSN
1538-3687
DOI
10.1001/archopht.1962.00960030304030
Publisher site
See Article on Publisher Site

Abstract

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract To the Editor: —After reading Dr. Kaufman's solicited comments on my letter to you, I feel, in the interest of clarity, that some additional statements should be made.I certainly have no quarrel with Dr. Kaufman's position that IDU represents a significant advance in the therapy of herpetic keratitis. Indeed, studies with our own preparation of IDU certainly tend to support the therapeutic findings presented in his article with Drs. Nesburn and Maloney in the May issue of the Archives.In defense of my comment that IDU inhibits both viral and cellular DNA, I should like to call attention to Dr. Kaufman's statement in his article (p. 590) where he points out that after all, "this drug was developed because of possible cytotoxic properties"; therefore, the logical assumption is that it does affect cellular DNA. In order to inhibit effectively the abnormally large amount of DNA being synthesized within a

Journal

Archives of OphthalmologyAmerican Medical Association

Published: Aug 1, 1962

There are no references for this article.